Dr. Daniel Mark Alterman, MD

Dr. Alterman practices at Vascular and Vein Institute of the South in Germantown, Tennessee.

Dr. Alterman's NPI, 1124284427, was assigned on August 6, 2008. Dr. Alterman holds Tennessee license 47345.

Dr. Alterman's primary practice is Vascular and Vein Institute of the South, at 1385 W Brierbrook Rd, Germantown, TN 38138 in Shelby County. The practice phone is (561) 312-1082.

Dr. Alterman's primary practice is Vascular and Vein Institute of the South in Germantown, Tennessee. Dr. Alterman is also affiliated with Baptist Memorial Hospital-Memphis. The medical group on file is Vascular & Vein Institute of the South. Dmand AI also links Dr. Alterman to 3 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Alterman practices, 5 sites in all. Vendor and product names are available with a free account.

Vascular surgery is Dr. Alterman's primary specialty in the NPI Registry, under taxonomy code 2086S0129X. Dmand AI has Dr. Alterman's licenses on file in 4 states: Tennessee, Arkansas, Michigan and Mississippi.

CMS data shows 9,368 Medicare services from Dr. Alterman across 38 procedure codes in 2024, for 435 Medicare patients. Medicare paid $1,151,495 for them. Every service was in an office.

CMS counts 435 Medicare patients who saw Dr. Alterman in 2024. The largest group is 65 to 74, with 168 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 22% are also on Medicaid. Their average risk score is 3.99, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Alterman's median patient age at 67, with 57% women.

In 2024, Dr. Alterman wrote 42 Medicare Part D claims for 40 patients. 100% of them were for generic drugs. CMS names the drug for 38 of them, across 1 drug with 11 or more claims each, at $197 in total drug cost. In 2023, CMS named 144 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Alterman for performance year 2024, reported as part of a group. Dr. Alterman accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 128 procedures of leg revascularization (restoring blood flow) by Dr. Alterman, more than 99% of the clinicians it reports for that procedure.

CMS Open Payments shows 214 general payments to Dr. Alterman from 25 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 96% of the total. Medtronic, Inc. paid the most, $3,591.